139 related articles for article (PubMed ID: 37036503)
1. Comparable long-term survival outcomes of endoscopic therapy versus surgical therapy for T1-2N0M0 duodenal neuroendocrine tumors.
Liu Z; Gao J; Wang P; Yin F; Zeng C; Chen Y
Surg Endosc; 2023 Jul; 37(7):5444-5452. PubMed ID: 37036503
[TBL] [Abstract][Full Text] [Related]
2. Effects of endoscopic therapy and surgical resection on long-term survival outcomes in patients with duodenal gastrointestinal stromal tumors: a surveillance, epidemiology, and end result program analysis.
Yan H; Liu X; Yin L; Han H; Jin Y; Zhu X; Liu Z
Surg Endosc; 2022 Nov; 36(11):8030-8038. PubMed ID: 35437643
[TBL] [Abstract][Full Text] [Related]
3. Comparable long‑term survival outcomes of endoscopic treatment versus surgical treatment for gastrointestinal stromal tumors with a diameter of 5-10 cm.
Liu Z; Tao Q; Wu Y; Zeng C; Chen Y
Sci Rep; 2024 Apr; 14(1):8513. PubMed ID: 38609414
[TBL] [Abstract][Full Text] [Related]
4. Comparable long-term survival of patients with colorectal or gastric gastrointestinal stromal tumors treated with endoscopic vs. surgical resection.
Yin L; Wang J; Zhao R; Chen K; Ji Z; Ji G; Zhang X
Surg Endosc; 2022 Jun; 36(6):4215-4225. PubMed ID: 34622298
[TBL] [Abstract][Full Text] [Related]
5. Surgical and Endoscopic Resection of Duodenal Neuroendocrine Tumors Have Similar Disease-Specific Survival Outcome.
Mirzaie S; Park JY; Mederos MA; Girgis MD
J Gastrointest Surg; 2023 Nov; 27(11):2365-2372. PubMed ID: 37552388
[TBL] [Abstract][Full Text] [Related]
6. Long-term outcomes of endoscopic therapy versus surgical resection for 2-5 cm gastric gastrointestinal stromal tumors: A population-based comparative study.
Chai Y; Lin B; Zhong J; Wu X; Lin X; Ge X; Jiang J; Liang Z; Liu S; Gu C
Eur J Surg Oncol; 2024 Jun; 50(6):108262. PubMed ID: 38531231
[TBL] [Abstract][Full Text] [Related]
7. Management of Duodenal Neuroendocrine Tumors: Surgical versus Endoscopic Mucosal Resection.
Tran CG; Sherman SK; Suraju MO; Nayyar A; Gerke H; Abiad RGE; Chandrasekharan C; Ear PH; O'Dorisio TM; Dillon JS; Bellizzi AM; Howe JR
Ann Surg Oncol; 2022 Jan; 29(1):75-84. PubMed ID: 34515889
[TBL] [Abstract][Full Text] [Related]
8. Sublobar resection versus lobectomy for patients with stage T1-2N0M0 pulmonary typical carcinoid tumours: a population-based propensity score matching analysis.
Yang H; Mei T
Interact Cardiovasc Thorac Surg; 2022 Aug; 35(3):. PubMed ID: 35512177
[TBL] [Abstract][Full Text] [Related]
9. Metastasis Prevalence and Survival of Patients with T1-2 Gastric Neuroendocrine Tumor Treated with Endoscopic Therapy and Surgery.
Wang M; Cheng S; Zhu L; Xu T; Zhang J; Zhang Y; Ping J; Wang R
Dig Dis Sci; 2022 Jul; 67(7):3228-3238. PubMed ID: 34272627
[TBL] [Abstract][Full Text] [Related]
10. Comparable survival benefit of local excision versus radical resection for 10- to 20-mm rectal neuroendocrine tumors.
Chen Q; Chen J; Huang Z; Zhao H; Cai J
Eur J Surg Oncol; 2022 Apr; 48(4):864-872. PubMed ID: 34753616
[TBL] [Abstract][Full Text] [Related]
11. Surgical outcomes of patients with duodenal vs pancreatic neuroendocrine tumors following pancreatoduodenectomy.
Dong DH; Zhang XF; Lopez-Aguiar AG; Poultsides G; Rocha F; Weber S; Fields R; Idrees K; Cho C; Spolverato G; Maithel SK; Pawlik TM
J Surg Oncol; 2020 Sep; 122(3):442-449. PubMed ID: 32470159
[TBL] [Abstract][Full Text] [Related]
12. Endoscopic and surgical treatment of T1N0M0 colorectal neuroendocrine tumors: a population-based comparative study.
Zhu H; Zhao S; Zhang C; Ji K; Wu W; Yin L; Yan H; Zhou J; Tang R; Miao L
Surg Endosc; 2022 Apr; 36(4):2488-2498. PubMed ID: 33987767
[TBL] [Abstract][Full Text] [Related]
13. Endoscopic Management of Diminutive Duodenal Neuroendocrine Tumors.
Klemm N; Lu-Cleary D; Chahal D; Trasolini R; Lam E; Donnellan F
J Gastrointest Cancer; 2021 Jun; 52(2):448-453. PubMed ID: 33471257
[TBL] [Abstract][Full Text] [Related]
14. Survival comparison between endoscopic and surgical resection for non-ampullary duodenal neuroendocrine tumor (1-2 cm).
Xie J; Zhang Y; He M; Liu X; Xie P; Pang Y
Sci Rep; 2022 Sep; 12(1):15339. PubMed ID: 36097200
[TBL] [Abstract][Full Text] [Related]
15. Outcomes of Surgical and Endoscopic Resection of Duodenal Neuroendocrine Tumours (NETs): a Systematic Review of the Literature.
Dasari BVM; Al-Shakhshir S; Pawlik TM; Shah T; Marudanayagam R; Sutcliffe RP; Mirza DF; Muiesan P; Roberts KJ; Isaac J
J Gastrointest Surg; 2018 Sep; 22(9):1652-1658. PubMed ID: 29869091
[TBL] [Abstract][Full Text] [Related]
16. The role of surgery in older patients with T1-2N0M0 small cell lung cancer: A propensity score matching analysis.
Ning J; Ge T; Zhu S; Han Y; Ruan S; Ma Y; Liu R
Front Oncol; 2022; 12():958187. PubMed ID: 36249007
[TBL] [Abstract][Full Text] [Related]
17. Observational study of surgical resection in small non-functional pancreatic neuroendocrine tumors: AS SEER-based study.
Lin J; Huang H
Sci Rep; 2023 Aug; 13(1):12824. PubMed ID: 37550460
[TBL] [Abstract][Full Text] [Related]
18. Role of Removed Lymph Nodes on the Prognosis of M0 Small-Bowel Neuroendocrine Tumors: a Propensity Score Matching Analysis from SEER Database.
Xie JB; Pang YS; Li X; Wu XT
J Gastrointest Surg; 2021 Dec; 25(12):3188-3197. PubMed ID: 34109533
[TBL] [Abstract][Full Text] [Related]
19. Survival outcomes and surgical intervention of small intestinal neuroendocrine tumors: a population based retrospective study.
Wu L; Fu J; Wan L; Pan J; Lai S; Zhong J; Chung DC; Wang L
Oncotarget; 2017 Jan; 8(3):4935-4947. PubMed ID: 27903960
[TBL] [Abstract][Full Text] [Related]
20. A Survival Analysis of Patients with Localized, Asymptomatic Pancreatic Neuroendocrine Tumors: No Surgical Survival Benefit when Examining Appropriately Selected Outcomes.
Powers BD; Rothermel LD; Fleming JB; Strosberg JR; Anaya DA
J Gastrointest Surg; 2020 Dec; 24(12):2773-2779. PubMed ID: 31754990
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
